From TRIMTECH Therapeutics Sep 3 2025 TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the formation of its Scientific Advisory Board (SAB). Globally recognized leaders within the protein degradation and technology development fields, Professor Alessio Ciulli FRS FRSE FRSC and Dr Adam Gilbert, have been appointed as Chair and member of the SAB, respectively. The